Cargando…

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years

Detalles Bibliográficos
Autores principales:	Podzamczer, D, Tiraboschi, JM, Mallolas, J, Cárdenes, MA, Casas, E, Castro, A, Echevarria, S, Leal, M, Bernanldo de Quirós, JC Lopez, Moreno, S, Puig, T, Ribera, E, Villalonga, C, Gomez Sirvent, JL, Garcia Heranejos, JA, Lopez-Aldeguer, J, Barrufet, P, Force, L, Santos, I, Sanz, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113088/ http://dx.doi.org/10.1186/1758-2652-13-S4-P81

Ejemplares similares

Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients
por: Podzamczer, Daniel, et al.
Publicado: (2014)

Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death
por: Heck, Carley J. S., et al.
Publicado: (2020)

Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients
por: Macías, J, et al.
Publicado: (2010)

Preparation and Characterisation of Nevirapine Oral Nanosuspensions
por: Raju, Anju, et al.
Publicado: (2014)

Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Solid-State Characterization of Nevirapine
por: Sarkar, Mahua, et al.
Publicado: (2008)

Low-temperature study of a new nevirapine pseudopolymorph
por: da Silva, C. C. P., et al.
Publicado: (2007)

Séminaire Bourbaki : exposés 489–506
por: Borho, Walter, et al.
Publicado: (1978)

Development of a liposomal nanodelivery system for nevirapine
por: Ramana, Lakshmi N, et al.
Publicado: (2010)

DRESS Syndrome due to Nevirapine Treated with Methylprednisolone
por: Pott Junior, Henrique, et al.
Publicado: (2013)

Antioxidant modulation of nevirapine induced hepatotoxicity in rats
por: Awodele, Olufunsho, et al.
Publicado: (2015)

Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
por: Moorthy, Anitha, et al.
Publicado: (2009)

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
por: Aaron, Erika, et al.
Publicado: (2010)

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
por: Permar, Sallie R, et al.
Publicado: (2013)

Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020)

EFFECTS OF FK506 ON THE HEALING OF DIAPHYSEAL, CRITICAL SIZE DEFECTS IN THE RAT FEMUR
por: De la Vega, R.E., et al.
Publicado: (2020)

Nevirapine induced exfoliative dermatitis in an HIV-infected patient
por: Bhandarkar, Anoosha P., et al.
Publicado: (2011)

Floating Drug Delivery of Nevirapine as a Gastroretentive System
por: Vedha, Hari BN, et al.
Publicado: (2010)

Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS)
por: Gill, Shaman, et al.
Publicado: (2013)

Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine
por: Longstreet, Ashley R, et al.
Publicado: (2013)

Clinical and genetic determinants of nevirapine plasma trough concentration
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals
por: Panzade, Prabhakar, et al.
Publicado: (2021)

THU506 A Not-So-Simple Case Of Hyperparathyroidism
por: Bhatt, Plukshi J, et al.
Publicado: (2023)

Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011)

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992)

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL
por: Casado, JL, et al.
Publicado: (2010)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
por: Manosuthi, Weerawat, et al.
Publicado: (2007)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

Association of Nevirapine Levels with Rash or Hepatotoxicity Among HIV-Infected Thai Women
por: Ratanasuwan, Winai, et al.
Publicado: (2012)

In vivo Evaluation of Self Emulsifying Drug Delivery System for Oral Delivery of Nevirapine
por: Chudasama, A. S., et al.
Publicado: (2014)

Nevirapine induced Stevens–Johnson syndrome in an HIV infected patient
por: Singh, Harminder, et al.
Publicado: (2011)

Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
por: Ena, Javier, et al.
Publicado: (2012)

Sex differences in apolipoprotein A1 and nevirapine-induced toxicity
por: Marinho, Aline, et al.
Publicado: (2014)

2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
por: Antunes, Alexandra M. M., et al.
Publicado: (2013)

Nevirapine induced mitochondrial dysfunction in HepG2 cells
por: Paemanee, Atchara, et al.
Publicado: (2017)

Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
por: Shang, Hongxia, et al.
Publicado: (2019)

Factors associated with stockout of Nevirapine syrup in Oshana Region, Namibia
por: Magesa, Emmanuel, et al.
Publicado: (2020)

Mania associated with overdose of nevirapine in an adolescent: A case report
por: Raju, V. Venkatesh, et al.
Publicado: (2021)

Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
por: Martínez, E, et al.
Publicado: (2010)

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jr3dk3qf7fvtl845c9ha74bnql